ArticlePDF AvailableLiterature Review

Robotic distal pancreatectomy and splenectomy: rationale and technical considerations

Authors:

Abstract and Figures

Minimally invasive distal pancreatectomy has had significant adoption in the United States over the past decade. Robotic distal pancreatectomy is a type of minimally invasive technique which affords greater dexterity and visualization compared to traditional laparoscopy. In addition to standard distal pancreatectomy procedures with or without splenectomy, the use of robotic surgical systems has been efficacious in performing more complex techniques such as radical antegrade modular pancreatosplenectomy (RAMPS) or spleen-preservation. There are important technical considerations to performing robotic distal pancreatectomy procedures which differ from other minimally invasive approaches. The purpose of this report is to describe the rationale and technical considerations for implementation of robotic distal pancreatectomy procedures in clinical practice.
Content may be subject to copyright.
© Journal of Visualized Surgery. All rights reserved. J Vis Surg 2017;3:135jovs.amegroups.com
Introduction
Minimally invasive distal pancreatectomy has become
the most commonly performed technique for distal
pancreatectomy in the United States (1). A majority of
surgeons had utilized laparoscopic techniques for minimally
invasive distal pancreatectomy prior to the advent of
modern robotic surgical systems. In contrast to traditional
laparoscopy, robotic distal pancreatectomy has been shown
to be feasible in performing both standard and more
complex resections with greater technical demands (2-4).
To date, there is no standardized approach to minimally
invasive distal pancreatectomy to guide surgeons in
selecting the most appropriate technique for an individual
patient. Cost considerations and surgeon-specific
experience or competency level are oftentimes used as the
main determinants for performing a specic technique (1,5).
With increased availability and a potentially shorter
learning curve, robotic distal pancreatectomy may be a
useful modality in increasing the successful adoption and
application of minimally invasive distal pancreatectomy.
The purpose of this report is to describe the rationale and
technical approach for the implementation of robotic distal
pancreatectomy.
Rationale
Robotic surgical systems provide more instrument range of
motion and control compared to traditional laparoscopic
instruments. Hand movement in standard laparoscopy leads
to exponentially increased instrument movement which
makes dissection around sensitive structures challenging. In
contrast, robotic surgical systems allow manipulation of the
Review Article on Pancreatic Surgery
Robotic distal pancreatectomy and splenectomy: rationale and
technical considerations
Nelson A. Royall, R. Matthew Walsh
Department of General Surgery, Digestive Disease Institute, Cleveland Clinic Foundation, Cleveland, Ohio, USA
Contributions: (I) Conception and design: All authors; (II) Administrative support: None; (III) Provision of study materials or patients: None; (IV)
Collection and assembly of data: All authors; (V) Data analysis and interpretation: All authors; (VI) Manuscript writing: All authors; (VII) Final
approval of manuscript: All authors.
Correspondence to: Dr. R. Matthew Walsh, MD, FACS. Professor and Chairman, Rich Family Chair of Digestive Diseases, Chairman. A100,
9500 Euclid Ave, Cleveland, OH 44195, USA. Email: walshm@ccf.org.
Abstract: Minimally invasive distal pancreatectomy has had significant adoption in the United States
over the past decade. Robotic distal pancreatectomy is a type of minimally invasive technique which affords
greater dexterity and visualization compared to traditional laparoscopy. In addition to standard distal
pancreatectomy procedures with or without splenectomy, the use of robotic surgical systems has been
efcacious in performing more complex techniques such as radical antegrade modular pancreatosplenectomy
(RAMPS) or spleen-preservation. There are important technical considerations to performing robotic
distal pancreatectomy procedures which differ from other minimally invasive approaches. The purpose of
this report is to describe the rationale and technical considerations for implementation of robotic distal
pancreatectomy procedures in clinical practice.
Keywords: Pancreatectomy; pancreatic diseases; robotic surgical procedures; robotics; minimally invasive surgical
procedures
Received: 22 April 2017; Accepted: 27 July 2017; Published: 30 September 2017.
doi: 10.21037/jovs.2017.08.01
View this article at: http://dx.doi.org/10.21037/jovs.2017.08.01
Journal of Visualized Surgery, 2017
© Journal of Visualized Surgery. All rights reserved. J Vis Surg 2017;3:135jovs.amegroups.com
Page 2 of 6
hand to instrument movement ratio, which allows for safe
dissection of delicate structures which otherwise require
high psychomotor ability. In the situation of a standard
distal pancreatectomy, there is limited need to manipulate
the hand to instrument movement ratio and does not require
signicant instrument articulation. Standard port placement
and in-line laparoscopic instruments, such as a Maryland
dissector and right-angle dissector, are generally adequate
for dissection of the splenic vein and artery or other
structures in a standard distal pancreatectomy with total
splenectomy. In contrast, the use of articulating instruments
and manipulating the hand to instrument movement ratio
may change the ability to complete a minimally invasive
distal pancreatectomy without open conversion in those
patients with significant peripancreatic fibrosis, enlarged
tumors, or other challenging anatomy. Table 1 provides a
relative comparison of traditional laparoscopy and robotic
techniques for distal pancreatectomy procedures.
For patients with locally advanced pancreatic tumors or
those warranting a more thorough lymphadenectomy [i.e.,
radical antegrade modular pancreatosplenectomy (RAMPS)]
the use of the robotic system has particular appeal (6). In
locally advanced pancreatic body and tail tumors the use
of the robotic systems can aid the surgeon in performing
en bloc resections of the involved structures such as the
duodenum or adrenal gland. Additionally, the robotic
system is decidedly more straightforward for the surgeon to
perform hand-sewn anastomoses should they be necessary
in the case of a bowel anastomosis or oversewing of vessels.
The full wrist articulation mimicking the surgeon’s hand can
make performing these anastomoses more straightforward,
particularly in the case of a surgeon less comfortable with
advanced intracorporal suturing skills.
Further, robotic surgical systems are advantageous
in RAMPS procedures where the gastroduodenal and
infra-pancreatic lymph node basins must be resected to
Table 1 A relative comparison of applications of laparoscopy and robot-assisted minimally invasive distal pancreatectomy
Technique
Psychomotor level
Ergonomic
comfort
Open
conversion
Procedural
cost
Primary
surgeon
First
assistant
Standard distal pancreatectomy with total splenectomy
Laparoscopy ––––
Robotic ––––
Distal pancreatectomy with total splenectomy and enterectomy and/or adrenalectomy
Laparoscopy ↑↑↑ ↑↑↑ ↓ ↑↑↑
Robotic ––↑ ↑
Distal pancreatectomy with total splenectomy and celiac axis resection (modified Appleby procedure)
Laparoscopy ↑↑↑↑ ↑↑↑ ↓ ↑↑↑ ↓
Robotic ↑↑ ––↑ ↑
RAMPS
Laparoscopy ↑↑↑ ↑↑ ↓ ↑↑
Robotic –––
Distal pancreatectomy with spleen-preservation (vessel-preservation technique)
Laparoscopy ↑↑↑ ↑↑ ↓ ↑↑
Robotic ––↑ ↑
Distal pancreatectomy with spleen-preservation (Warshaw technique)
Laparoscopy ↑↑↓↑
Robotic ––↑ ↑
RAMPS, radical antegrade modular pancreatosplenectomy.
Journal of Visualized Surgery, 2017
© Journal of Visualized Surgery. All rights reserved. J Vis Surg 2017;3:135jovs.amegroups.com
Page 3 of 6
complete the N1 dissection. Clearance of nodal tissue
along the right gastroepiploic vein, gastroduodenal artery,
and common hepatic artery is believed to be a critical
component for the survival advantage noted in RAMPS (6).
Although a pure laparoscopic approach may be feasible,
many pancreatic surgeons are unlikely to feel comfortable
with this dissection given the limited dexterity of current
laparoscopic instruments. In minimally invasive RAMPS,
careful dissection and mobilization of perivascular
lymphatic tissue is greatly facilitated using fully articulating
instruments which can also be adjusted to decrease the hand
to instrument movement (4).
A nal technical modication of the distal pancreatectomy
which can be facilitated using the robotic system is spleen-
preservation (2,3,7). In spleen preserving techniques where
pancreatic branches from the splenic vein and artery are
individually ligated and sutured (splenic vessel preservation),
robotic surgical systems increase the likelihood of successful
splenic preservation compared to traditional laparoscopy
(2,3). This effect can be explained by the impact of the
robotic instrument articulation providing greater needle
dexterity which is critical in ligating small venous or arterial
branches along the relatively thin-walled splenic vein.
Given the number of sutures required, surgeon comfort
also becomes a greater consideration during these types
of technically demanding procedures and the improved
ergonomics seen with robotic surgical systems can help
prevent surgeon discomfort and fatigue throughout the
procedure. In comparison, the Warshaw technique (non-
splenic vessel preserving) where the splenic vein and artery
are divided, the ability to carefully dissect the splenic
vein tributaries seen in the diffuse splenic vein anatomy is
challenging in pure laparoscopy. Robotic instrumentation
with articulation and modication of the hand to instrument
movement ratio appears to aid in minimizing blood loss
and completing the procedure with a minimally invasive
approach.
Considerations
Robotic surgical systems require institutional credentialing
prior to use (8). Furthermore, mentorship to develop
competency in robotic instrumentation is critical to avoid
life-threatening injuries which can be seen with any surgical
instrument (8). Although robotic surgical systems are
certainly more generalizable to the traditional surgeon
compared to laparoscopic techniques, training in safe
trochar and robot-specic instrument use must be obtained
prior to implementing the technology in clinical practice.
With respect to robotic distal pancreatectomy, trochar
placement is similar to those used in laparoscopic distal
pancreatectomy. Depending on the robotic surgical system
used and preferred instrumentation, the trochars are a
combination of either 5, 8, or 12 mm in diameter. The patient
should be deemed a safe candidate for pneumoperitoneum
and if intraperitoneal adhesions exist then trochar placement
may need to be staged with adhesiolysis performed until all
trochars can be placed under direct visualization.
Most minimally invasive distal pancreatectomy procedures
utilize endoscopic stapling devices to transect the pancreatic
parenchyma. Both robotic stapling devices, depending on
the surgical system used, and laparoscopic stapling devices
can be used. Parenchymal suturing at the transection margin
can be performed depending on surgeon preference and
does increase the degree of technical challenge encountered
compared to open techniques. If a RAMPS procedure is
performed, additional trochars are used to aid in performing
the hepatoduodenal ligament and infra-pancreatic lymph
node dissections. The assistant port in RAMPS procedures
is of greater importance to retract or hold structures during
the dissection. In the setting of a locally advanced tumor
requiring duodenal resection, table manipulation may be
needed during the procedure while mobilizing the ligament
of Treitz. Although commercially available operative tables
are available which coordinate table movement with the
robotic system, if not available the robotic system will need
to be undocked from the patient to manipulate the operative
table during this portion of the procedure.
Technique
The peritoneal cavity can be entered in a variety of methods
including traditional laparoscopic techniques or a robot-
assisted method. Utilizing the robotic camera with an
optical view trochar in the left aspect of the epigastrium is a
cost-effective method we utilize to avoid use of laparoscopic
equipment. Additional trochars are then placed in the right
anterior axillary line, right para-median, supraumbilical, left
para-median, and left anterior axillary line. The size of the
trochars depends on the robotic device utilized. Examples of
port placement are demonstrated for the Intuitive Da Vinci
Si and Xi systems for distal pancreatectomy in Figures 1,2.
The potential use of smaller trochars such as robotic 5 mm
trochars has the advantage of a potentially lower risk for
incisional hernia, although the instruments at this time are
more limited in the existing robotic systems and not ideal
Journal of Visualized Surgery, 2017
© Journal of Visualized Surgery. All rights reserved. J Vis Surg 2017;3:135jovs.amegroups.com
Page 4 of 6
for robotic distal pancreatectomy.
After placement of the robotic trochars, the epigastric
trochar is removed and the camera repositioned to the
supraumbilical trochar site. A liver retractor such as the
Nathanson retractor is placed through the epigastric port
site. The robotic surgical system is then docked from either
above the head or obliquely depending on the surgical
system used. The rst assistant is positioned on the patient’s
left side and will utilize the left para-median trochar
for suctioning and potentially stapled transection of the
pancreas. The surgeon at this point moves to the robotic
console after ensuring correct placement of the desired
instruments. An example of an instrument orientation
would be an atraumatic grasping device in the right anterior
axillary and left anterior axillary trochars with an ultrasonic
dissector or bipolar dissector in the right para-median
trochar.
The operation proceeds similar to previous descriptions
of distal pancreatectomy depending on the extent of
lymphadenectomy or performance of splenic preservation.
Figure 3 demonstrates the standard technique for a robot-
assisted distal pancreatectomy with splenectomy. For a
standard distal pancreatomy with total splenectomy, the
gastrosplenic ligament and short gastric vessels are serially
divided using the dissecting device up to the level of the
left phrenoesophageal ligament. The stomach is grasped
and retracted lateral and caudal using the right anterior
axillary grasping device while the left anterior axillary
grasping device retracts the greater omentum caudal. The
right anterior axillary grasping device serially regrasps the
posterior aspect of the stomach and rotates the stomach
counter-clockwise to better expose the gastric fundus and
Figure 1 Sample port placement for robotic distal pancreatectomy
with an Intuitive Da Vanci Si system. Eight mm trochars are
utilized for instrument arms and the supra-umbilical trochar is
used for the camera and eventual specimen removal. The 12 mm
left para-median trochar is used for the assistant port in addition to
the site for a stapling device if used.
Figure 2 Sample port placement for robotic distal pancreatectomy
with an Intuitive Da Vanci Xi system. Eight mm trochars are
utilized for instrument arms and the supra-umbilical trochar is
used for the camera and eventual specimen removal. The 12 mm
left para-median trochar is used for the assistant port in addition to
the site for a stapling device if used.
Figure 3 Technique for robotic-assisted distal pancreatectomy and
splenectomy (9).
Available online: http://www.asvide.com/articles/1719
Video 1. Technique for robotic-assisted
distal pancreatectomy and splenectomy
Nelson A. Royall, R. Matthew Walsh*
Department of General Surgery, Digestive Disease
Institute, Cleveland Clinic Foundation, Cleveland,
Ohio, USA
Journal of Visualized Surgery, 2017
© Journal of Visualized Surgery. All rights reserved. J Vis Surg 2017;3:135jovs.amegroups.com
Page 5 of 6
cardia while dividing the gastrosplenic ligament. The
superomedial aspect of the splenodiaphragmatic ligament
can be divided at this point as well given the excellent
exposure. The liver retractor is re-positioned to retract the
stomach and liver anteriorly. Similarly a Penrose drain can
be placed to similarly retract the stomach anteriorly.
The gastrocolic ligament is divided in conjunction
with the gastrosplenic ligament up to the level of the
right gastroepiploic vein depending on the extent of
pancreatectomy and lymphadenectomy desired. If a distal
pancreatectomy at the level of the superior mesenteric vein
is necessary then the right gastroepiploic vein is followed
distally to the junction with the superior mesenteric vein
while retracting the stomach anteriorly with the left
anterior axillary grasping device. The peritoneum overlying
the superior mesenteric vein and caudal aspect of the
pancreatic neck or body is divided using an electrosurgical
device or dissector. The peritoneum along the caudal aspect
of the pancreatic body and tail is similarly divided to allow
for caudal retraction of the colon and transverse mesocolon
to prevent an iatrogenic mesocolic defect.
A retro-pancreatic tunnel is created using blunt dissection
with the right and left anterior axillary grasping at the
level of the superior mesenteric vein. The dissection ends
at the cephalad aspect of the pancreas beyond the level
of the splenic vein. The dissection proceeds anteriorly at
the cephalad aspect of the pancreas to isolate the splenic
artery. The splenic artery should be followed proximally
to the celiac trunk and all lymphatic tissue dissected from
the splenic artery and celiac trunk to be included with
the specimen. A laparoscopic or robotic ultrasound probe
should be routinely employed to evaluate the pancreatic
parenchyma, identify the pancreatic lesion, and main
pancreatic duct. The ultrasound exam is additionally used
to guide the level of pancreatic parenchyma transection
ensuring an adequate margin is achieved.
Except in the case of splenic vessel preservation, the
splenic artery is divided at the level of the celiac trunk or
distally to preserve the dorsal pancreatic artery. The splenic
artery can be divided using either surgical clips or a surgical
vascular stapler load. The splenic vein is then bluntly
dissected from the pancreatic parenchyma circumferentially
on the posterior aspect of the pancreatic body at the level
of the planned parenchymal transection. The splenic vein
is divided using either surgical clips or a surgical vascular
stapler load. The pancreatic parenchyma can be divided at
this step using a variety of transection techniques including
a surgical stapling device, electrosurgical dissector, ultrasonic
dissector, or sharp transection. If desired the pancreatic
transection stump and main pancreatic duct can be over
sewn using robotic needle drivers placed through the left
anterior axillary trochar.
The pancreatic body and tail are then elevated anteriorly
using the right anterior axillary trochar while the transverse
colon is retracted caudal. The splenocolic ligament is
divided using either a monopolar or a surgical dissecting
device to mobilize the splenic flexure of the colon. The
splenorenal ligament can be divided at this point with
adequate caudal retraction of the transverse colon. The
retro-pancreatic lymphatic tissue is then divided using
either an ultrasonic or bipolar dissector to complete
the retro-pancreatic lymphadenectomy. The remaining
splenodiaphragmatic and splenorenal ligaments are divided
as well to complete the resection.
There are two predominant methods for specimen
removal in minimally invasive distal pancreatectomy with
splenectomy. The specimen can be left intact or the distal
pancreas can be divided from the spleen and the specimens
removed separately. There has been no evidence suggesting
a benefit of maintain the specimen intact at the time of
removal assuming the lesion is not violated by performing
this maneuver. The most commonly utilized extraction site
for the specimen is the supra-umbilical trochar site which
requires replacement of the robotic camera to the right
para-median or left para-median trochar depending on the
surgical system utilized. Prior to removal of the specimens a
surgical drain can be placed through the left anterior axillary
trochar site with removal of the trochar. The specimens
are placed within a protective bag to avoid trochar site
seeding or contamination. The extraction trochar often
requires enlargement for specimen removal. Trochar fascial
defects can be closed using either a transfascial or anterior
approach.
Conclusions
Robotic distal pancreatectomy is a valuable technique
for performing minimally invasive distal pancreatectomy.
The increased dexterity afforded by the robotic surgical
systems can aid the surgeon, particularly during lymph node
dissections such as those in a RAMPS procedure or vascular
dissection such as spleen-preserving techniques. Further
investigations which will attempt to expand the body of
evidence on the role of robotic distal pancreatectomy may
be important to clarifying how to best implement the
technology.
Journal of Visualized Surgery, 2017
© Journal of Visualized Surgery. All rights reserved. J Vis Surg 2017;3:135jovs.amegroups.com
Page 6 of 6
Acknowledgements
None.
Footnote
Conicts of Interest: The authors have no conicts of interest
to declare.
References
1. Rosok BI, de Rooij T, van Hilst J, et al. Minimally invasive
distal pancreatectomy. HPB (Oxford) 2017;19:205-14.
2. Chen S, Zhan Q, Chen JZ, et al. Robotic approach
improves spleen-preserving rate and shortens postoperative
hospital stay of laparoscopic distal pancreatectomy: a
matched cohort study. Surg Endosc 2015;29:3507-18.
3. Eckhardt S, Schicker C, Maurer E, et al. Robotic-Assisted
Approach Improves Vessel Preservation in Spleen-Preserving
Distal Pancreatectomy. Dig Surg 2016;33:406-13.
4. Lee SH, Kang CM, Hwang HK, et al. Minimally invasive
RAMPS in well-selected left-sided pancreatic cancer
within Yonsei criteria: long-term (>median 3 years)
oncologic outcomes. Surg Endosc 2014;28:2848-55.
5. Magge D, Gooding W, Choudry H, et al. Comparative
effectiveness of minimally invasive and open distal
pancreatectomy for ductal adenocarcinoma. JAMA Surg
2013;148:525-31.
6. Strasberg SM, Drebin JA, Linehan D. Radical antegrade
modular pancreatosplenectomy. Surgery 2003;133:521-7.
7. Lee LS, Hwang HK, Kang CM, et al. Minimally Invasive
Approach for Spleen-Preserving Distal Pancreatectomy:
a Comparative Analysis of Postoperative Complication
Between Splenic Vessel Conserving and Warshaw's
Technique. J Gastrointest Surg 2016;20:1464-70.
8. Melvin WS. Robots in surgery: advanced gastrointestinal
applications and credentialing. J Gastrointest Surg
2003;7:481-3.
9. Royall NA, Walsh RM. Technique for robotic-assisted
distal pancreatectomy and splenectomy. Asvide 2017;4:405.
Available online: http://www.asvide.com/articles/1719
doi: 10.21037/jovs.2017.08.01
Cite this article as: Royall NA, Walsh RM. Robotic distal
pancreatectomy and splenectomy: rationale and technical
considerations. J Vis Surg 2017;3:135.
... Surgical System (Intuitive Surgical, Inc., Sunnyvale, CA), surgeons can potentially overcome the limitations of traditional laparoscopy due to better dexterity from the patented endo-wrist, three-dimensional (3D) visualization, and better ergonomics. [7][8][9][10][11][12] Some studies have shown that robotic surgery is a safe and feasible approach to DP but requires a longer operative time. 1,5 However, presently there is no consensus on which approach (robotic or laparoscopic) is better as both techniques appear equivalent. ...
... 1,5 However, presently there is no consensus on which approach (robotic or laparoscopic) is better as both techniques appear equivalent. [10][11][12][13][14][15] This study summarizes our experience with robotic (RDP) and laparoscopic distal pancreatectomies (LDP), comparing between the clinical outcomes of RDP versus LDP. ...
... During MIDP, the increased dexterity of the robotic arms has been shown to facilitate suturing and fine dissection in tight spaces allowing for more precise dissection of the splenic vessels from the pancreatic parenchyma. 2,11,12,24 These advantages have been shown to enable surgeons to perform splenic vessel preservation during MIDP. 1,2,10,14,[24][25][26] The results of our study also seem to support this hypothesis. ...
Article
Full-text available
Backgrounds/aims: This study aims to describe our experience with minimally-invasive distal pancreatectomies, with emphasis on the comparison between robotic distal pancreatectomy (RDP) and laparoscopic distal pancreatectomy (LDP). Methods: Retrospective review of 102 consecutive RDP and LDP from 2006 to 2019 was performed. Results: There were 27 and 75 patients who underwent RDP and LDP, respectively. There were 12 (11.8%) open conversions and 16 (15.7%) patients had major (>grade 2) morbidities. Patients who underwent RDP had significantly higher rates of splenic preservation (44.4% vs. 13.3%, p=0.002), higher rates of splenic-vessel preservation (40.7% vs. 9.3%, p=0.001), higher median difficulty score (5 vs. 3, p=0.002) but longer operation time (385 vs. 245 minutes, p<0.001). The rate of open conversion tended to be lower with RDP (3.7% vs. 14.7%, p=0.175). Conclusions: In our institution practice, both RDP and LDP were safe and effective. The use of RDP appeared to be complementary to LDP, allowing us to perform more difficult procedures with comparable postoperative outcomes.
... Distal pancreatectomy is a classical radical operation for patients with tumors located in the body and tail of the pancreas. Robot-assisted minimally invasive surgery has been preferred for those patients with benign or borderline lesions who have proper surgical conditions to meet the need for rapid recovery [27]. However, POPF is the main complication of pancreatic surgery, which may prolong recovery. ...
Article
Full-text available
Objectives Postoperative pancreatic fistula (POPF) is the main complication of distal pancreatectomy (DP) and affects the prognosis of patients. The impact of several clinical factors mentioned in recent studies on POPF remains controversial. This study aimed to investigate the impact of a remnant pancreas and other perioperative factors on POPFs occurring after robot-assisted distal pancreatectomy (RDP) for nonmalignant pancreatic neoplasms. Methods A total of 197 patients who received robot-assisted distal pancreatectomy (RDP) for nonmalignant pancreatic neoplasms at the Pancreatic Disease Center, Ruijin Hospital Shanghai Jiaotong University School of Medicine from January 2018 to December 2020 were included in this retrospective study. According to the intraoperative transection plan, patients were divided into an RDP body group and an RDP tail group. Clinical and pathological features and perioperative factors affecting POPF were analyzed and compared between the two groups. Results The results showed that a transection plan involving the tail of the pancreas (OR = 2.133, 95% CI 1.109–4.103, p = 0.023) and spleen preservation (OR = 2.588, 95% CI 1.435–4.665, p = 0.001) independently increased the incidence of POPF in patients with nonmalignant pancreatic neoplasms treated by RDP. A transection plan involving the tail of the pancreas was also an independent risk factor (OR = 3.464, 95% CI 1.270–9.450, p = 0.015) for grade B/C POPF. Length of remnant pancreas > 6.23 cm was an independent risk factor for POPF (OR = 3.116, 95% CI 1.364–7.121, p = 0.007). Length of remnant pancreas > 9.82 cm was an independent risk factor for grade B/C POPF (OR = 3.340, 95% CI 1.386–8.051, p = 0.007). Conclusion This retrospective study suggests that a transection plan involving the tail of the pancreas is an independent risk factor for POPF in patients with nonmalignant neoplasms treated by RDP. We also propose that the postoperative length of the remnant pancreas evaluated by computed tomography scans can be used to identify patients with a high risk of POPF in order to optimize the individualized strategy.
... Although as Cao et al. state further, trial data are needed before confirmation of the survival benefits of RAMPS which can be assessed although the authors state that based upon their meta-analysis, RAMPS is an oncologically superior procedure [66]. Finally, the use of robotic DPS/RAMPS for PDAC may allow further advances in the radicality of dissection and regional lymphadenectomy although robust data on this is required [67]. ...
Article
Full-text available
Surgical options and approaches to pancreatic cancer are changing in the current era. Neoadjuvant treatment strategies for pancreatic cancer combined with the increased use of minimal access surgical techniques mean that the modern pancreatic surgeon requires mastering a number of surgical approaches with to optimally manage patients. Whilst traditional open surgery remains the most frequent approach for surgery, the specific steps during surgery may need to be modified in light of the aforementioned neoadjuvant treatments. Robotic and laparoscopic approaches to pancreatic resection are feasible, but these surgical methods remain in their infancy. In this review article, we summarise the current surgical approaches to pancreatic cancer and how these are adapted to the minimal access setting with discussion of the patient outcome data.
... All cases achieved R0 resection without tumor recurrence and mortality within two years, which preliminarily showed the feasibility of robotic RAMPS. Compared to laparoscopic surgery, the application of robotic surgery can lower the difficulty of pancreatic vessel skeletonization and regional lymphadenectomy (60). In general, the use of robotic RAMPS mainly depends on the surgeon's preference (36). ...
Article
Full-text available
The robotic surgical system has been applied to various types of pancreatic surgery. However, controversies exist regarding a variety of factors including the safety, feasibility, efficacy, and cost-effectiveness of robotic surgery. This study aimed to evaluate the current status of robotic pancreatic surgery and put forth experts' consensus and recommendations to promote its development. Based on the WHO Handbook for Guideline Development, a Consensus Steering Group* and a Consensus Development Group were established to determine the topics, prepare evidence-based documents, and generate recommendations. The GRADE Grid method and Delphi vote were used to formulate the recommendations. A total of 19 topics were analyzed. The first 16 recommendations were generated by GRADE using an evidence-based method (EBM) and focused on the safety, feasibility, indication, techniques, certification of the robotic surgeon, and cost-effectiveness of robotic pancreatic surgery. The remaining three recommendations were based on literature review and expert panel opinion due to insufficient EBM results. Since the current amount of evidence was low/meager as evaluated by the GRADE method, further randomized controlled trials (RCTs) are needed in the future to validate these recommendations.
Chapter
In recent years, with the research progress of spleen immune function, more and more scholars began to pay attention to the immune function of spleen, especially in teenagers and children, and the requirements of spleen preserving surgery in clinic are increasingly high. Compared with total splenectomy, partial splenectomy has the advantage of avoiding the risk of infection and thrombosis after total splenectomy, and the disadvantage is increased risk of perioperative bleeding. The anatomical operation of partial splenectomy is more complicated, and the intraoperative bleeding is easy to affect the operation, so the technical and experience requirements of the operator are higher.
Chapter
Review the history of minimally invasive splenectomy. In 1991, Delaitre et al. reported the first Laparoscopic Splenectomy (LS). In 1993, Tulman et al. applied LS to the field of pediatric surgery. In 2003, Talamini et al. reported seven Robotic Splenectomy (RS) operations. In 2013, Ruan Hu, Jiang Zhiwei et al. reported five cases of RS surgery in China. In the field of pediatric surgery, Mbaka et al. summarized and reported 32 cases of robotic splenectomy in children in 2017. At present, there is no report on the applications of robotic splenectomy in children in China.
Article
Background The aim of this study was to assess the perioperative and pathologic outcomes of robotic distal pancreatectomy compared with a laparoscopic approach. Methods A total of 121 robotic distal pancreatectomies and 992 laparoscopic distal pancreatectomies were retrospectively evaluated, comparing the demographic, perioperative and pathologic outcomes. After 1:2 propensity score matching with 11 demographic variables, the factors were analyzed again. Results Following propensity score matching, 104 robotic distal pancreatectomy patients were compared with 208 laparoscopic distal pancreatectomy patients. The operation time and proportion of spleen preservation were not different between the groups. The rates of open conversion were lower, whereas the hospital costs were higher in the robotic group. Other perioperative outcomes and pathologic factors did not differ between the groups. Conclusions Although robotic distal pancreatectomy is more expensive, this operation is feasible, with a higher probability of proceeding with the planned operation and with low open conversion rate. This article is protected by copyright. All rights reserved.
Chapter
Chronic pancreatitis (CP) is characterized by recurrent inflammatory episodes of the pancreas, resulting in fibrotic replacement of pancreatic parenchyma and leading to progressive loss of pancreatic exocrine and/or endocrine function. The most frequent indication for surgical treatment of patients with CP is pain. There are contraindications for surgical treatment, in addition to patient comorbidity and limited physiological reserve. Surgical treatment of CP can be offered in selected patients with portal hypertension secondary to portal/superior mesenteric vein thrombosis, but great caution is advised. Patients have often experienced months or years of symptoms before receiving a diagnosis of CP, and this can have a toll on their physical, psychological, and nutritional state. Timing of surgery in CP has been examined in both observational studies and a clinical trial.
Article
Background: The first International conference on Minimally Invasive Pancreas Resection was arranged in conjunction with the annual meeting of the International Hepato-Pancreato-Biliary Association (IHPBA), in Sao Paulo, Brazil on April 19th 2016. The presented evidence and outcomes resulting from the session for minimally invasive distal pancreatectomy (MIDP) is summarized and addressed perioperative outcome, the outcome for cancer and patient selection for the procedure. Methods: A literature search was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines to compare MIDP and open distal pancreatectomy. Patient selection was discussed based on plenary talks, panel discussions and a worldwide survey on MIDP. Results: Of 582 studies, 52 (40 observational and 12 case-matched) were included in the assessment for outcome for LDP (n = 5023) vs. ODP (n = 16,306) whereas 16 observational comparative studies were identified for cancer outcome. No randomized trials were identified. MIDP resulted in similar outcome to ODP with a tendency for lower blood loss and shorter hospital stay in the MIDP group. Discussion: Available evidence for comparison of MIDP to ODP is weak, although the number of studies is high. Observed outcomes of MIDP are promising. In the absence of randomized control trials, an international registry should be established.
Article
Background: Vessel-preserving spleen preservation (SP) during distal pancreatectomy (DP) is supposed to be beneficial for patients with benign and borderline tumors. This study evaluated the first experiences with robotic-assisted laparoscopic DP (RA-LDP) and its rate of vessel preservation and SP compared to conventional laparoscopic DP (C-LDP). Methods: Patients scheduled for spleen-preserving DP for benign or borderline tumors by either C-LDP or RA-LDP were retrieved from a prospective database and retrospectively analyzed regarding vessel-preservation and SP, conversion rate, blood loss, operating time, complications, perioperative blood transfusion, postoperative hospital stay (PHS) and mortality. Results: Twenty-nine patients underwent C-LDP and 12 patients underwent RA-LDP between September 2009 and May 2015. SP rates were 79% (23 of 29) in the C-LDP and 92% (11 of 12) in the RA-LDP group (p = 0.32). Splenic vessels could be preserved in 17% (5 of 29) of the C-LDP and 50% (6 of 12) of the RA-LDP group (p = 0.052). Operating time, intraoperative blood loss, the number of perioperative red blood cell transfusions, overall morbidity and the rate of postoperative pancreatic fistulas were not different between the groups. PHS was shorter in the RA-LDP group (10.5 vs. 13 days; p = 0.02). Conclusion: RA-LDP for benign or borderline tumors of the pancreas is a safe procedure and tended to be associated with a better vessel-preservation rate, thereby making it a good alternative to C-LDP.
Article
Background: Spleen-preserving distal pancreatectomy with Warshaw's technique (WT) was reported to have higher spleen-related complication. The aim of this study was to evaluate the postoperative complication between the splenic vessel-conserving technique (SVC) and the WT when they were performed by the minimally invasive approach. Methods: From January 2006 to June 2015, data of the patients who had laparoscopic or robotic-assisted spleen-preserving distal pancreatectomy for benign or borderline malignant tumors were retrospectively reviewed. Patients were divided into SVC and the WT group for comparison. Results: Of the 89 patients who had the spleen-preserving distal pancreatectomy, 63 were SVC, whereas 26 were WT. The CT scans showed that patients who had WT were found to have higher rate of splenic infarction (P < 0.001) and had significantly higher rate of collateral vessel formation at 1 year (P < 0.001). All the splenic infarctions were low grade and asymptomatic which resolved spontaneously. None of the patients with collateral formation experienced gastrointestinal bleeding. The postoperative complication of SVC and WT did not differ significantly. Conclusion: SVC and WT were found to have comparable outcome. Both techniques can be used to achieve higher spleen-preserving rate.
Article
Spleen preservation (SP) is beneficial for patients undergoing distal pancreatectomy of benign and borderline tumors; however, the conventional laparoscopy approach (C-LDP) is less effective in controlling splenic vessel bleeding. The benefits of the robotic-assisted approach (RA-LDP) in SP have not been clearly described. This study aimed to evaluate whether a robotic approach could improve SP rate and effectiveness/safety profile of laparoscopic distal pancreatectomy (LDP). Matched for scheduled SP, age, sex, ASA classification, tumor size, tumor location, and pathological type, 69 patients undergoing RA-LDP and 50 undergoing C-LDP between January 2005 and May 2014 were included. Main outcome measures included SP rate, operative time (OT), blood loss, transfusion frequency, morbidity, postoperative hospital stay (PHS), and oncologic safety. Among matched patients scheduled for SP, RA-LDP was associated with significantly higher overall (95.7 vs. 39.4 %) and Kimura SP rates (72.3 vs. 21.2 %), shorter OT (median 120 vs. 200 min), less blood loss (median 100 vs. 300 mL), lower transfusion frequency (2.1 vs. 18.2 %), and shorter mean PHS (10.2 vs. 14.5 days). Among matched patients scheduled for splenectomy, RA-LDP was associated with similar OT, blood loss, transfusion frequency, and PHS. The two approaches were similar in overall morbidity, frequency of pancreatic fistula, and oncologic outcome among patients undergoing splenectomy for malignant tumors. RA-LDP was associated with a significantly better SP rate and reduced OT, blood loss, transfusion requirement, and PHS for patients undergoing SP compared to C-LDP, but offered less benefits for patients undergoing splenectomy.
Article
Background: Although minimally invasive techniques for distal pancreatectomy with or without splenectomy have been regarded as a feasible and safe treatment option for benign and borderline malignant lesions of the pancreas, the management of left-sided pancreatic cancer remains controversial. Methods: From June 2007 to November 2010, 12 patients underwent laparoscopic or robotic radical antegrade modular pancreatosplenectomy (RAMPS) for well-selected left-sided pancreatic cancer. The Yonsei criteria for patient selection included the following conditions: (1) tumor confined to the pancreas, (2) intact fascial layer between the distal pancreas and the left adrenal gland and kidney, and (3) tumor located more than 1-2 cm from the celiac axis. We compared the clinicopathologic factors and oncologic outcomes of the minimally invasive surgery (MIS) and the conventional open surgery groups for treating left-sided pancreatic cancer. Results: In the MIS group, the mean tumor size was 2.75 ± 1.32 cm, and the mean number of retrieved lymph nodes was 10.5 ± 7.14. The resection margins were confirmed to be negative for malignancy in all patients. The MIS group and open group (n = 78) were statistically different in terms of tumor size (2.8 ± 1.3 vs. 3.5 ± 1.9 cm, p = 0.05) and length of hospital stay (12.3 ± 6.8 vs. 22.4 ± 21.6 days, p = 0.002). On survival analysis, the MIS group had longer disease-free survival (DFS) and overall survival (OS) than the open group (DFS: 47.6 vs. 24.7 months, p = 0.027; OS: 60.0 vs. 30.7 months, p = 0.046). In order to overcome the heterogeneity of subjects between the MIS and the open group, we performed statically matched comparisons using the propensity score analysis and then divided the open group into two subgroups according to the Yonsei criteria. There were no significant differences in median overall survival between the MIS group and the open group that met the Yonsei criteria (60.00 vs. 60.72 months, p = 0.616). Conclusions: Minimally invasive RAMPS is not only technically feasible but also oncologically safe in cases of well-selected left-sided pancreatic cancer. Our selection criteria for minimally invasive RAMPS needs to be further validated based on additional large-volume studies.
Article
Importance Multicenter studies indicate that outcomes of open (ODP) and minimally invasive distal pancreatectomy (MIDP) are equivalent for benign lesions. However, data for pancreatic carcinoma are limited. Objective To compare outcomes of ODP and MIDP for early-stage pancreatic ductal carcinoma to determine relative safety and oncologic efficacy. Design Retrospective analysis of 62 consecutive patients undergoing ODP or MIDP for pancreatic ductal carcinoma by intention to treat with propensity scoring to correct for selection bias. Setting A high-volume university center for pancreatic surgery. Participants Sixty-two patients at a single institution. Interventions Patients underwent ODP or MIDP. Main Outcome Measures Perioperative mortality, morbidity, readmission, postoperative complications, disease progression, and overall survival. Results Thirty-four patients underwent ODP, and 28 underwent MIDP with 5 conversions to ODP. No significant differences in age, body mass index, performance status, tumor size, or radiographic stage were identified. High rates of margin-negative resection (ODP, 88%; MIDP, 86%) and median lymph node clearance (ODP, 12; MIDP, 11) were achieved in both groups with equal rates and severity of postoperative complications (ODP, 50%; MIDP, 39%) and pancreatic fistula (ODP, 29%; MIDP, 21%). Despite conversions, intended MIDP was associated with reduced blood loss (P = .006) and length of stay (P = .04). Conversion was associated with a poor histologic grade and positive nodes. Median overall survival for the entire cohort was 19 (95% CI, 14-47) months. Minimally invasive distal pancreatectomy was performed increasingly in later study years and for patients with a higher Charlson–Age Comorbidity Index. Overall survival after ODP or intended MIDP was equivalent after adjusting for comorbidity and year of surgery (relative hazard, 1.11 [95% CI, 0.47-2.62]). Conclusions and Relevance We detected no evidence that MIDP was inferior to ODP based on postoperative outcomes or overall survival. This conclusion was verified by propensity score analysis with adjustment for factors affecting selection of operative technique.
Article
ADVANCED GASTROINTESTINAL APPLICATIONS Advances in laparoscopic surgery have allowed the application of standard laparoscopic tasks to encompass most aspects of gastrointestinal surgery. New instrumentation, including advanced surgical systems (e.g., the da Vinci Surgical System; Intuitive Surgical, Inc., Sunnyvale, CA), are a continuation of this progress. Discussions of systems such as da Vinci require strict definitions. The term computer-assisted/enhanced telesurgery is most accurate. Other terms such as robotic surgery are frequently used but are imprecise in that they imply preprogrammed, autonomous devices, which currently are not available for widespread use. Computer-enhanced telesurgery can further define and enhance many aspects of advanced gastrointestinal surgery. The current limitations of laparoscopic surgery are well recognized. Rigid, unarticulated instruments that rotate around a fixed point in the abdominal wall reduce precision. Tissue manipulation and the ability to reach certain environments within the abdomen are limited. Moreover, standard laparoscopic instrumentation does not provide truedepth or three-dimensional imaging. The computerenhanced devices do. Additionally, the new devices offer motion scaling, which significantly adds to all fine-motor aspects of advanced gastrointestinal surgery. This level of enhancement is important when manipulating small structures or fine tissues and, at this time, provides the most apparent benefit of a computer-enhanced telesurgical device. The indications and actual advantages of the new devices for performing standard laparoscopic gastrointestinal surgery remain unclear, however. Numerous reports concur, including the largest combined series of 211 cases from four institutions describing a variety of completed gastrointestinal and intra
Article
Retrograde distal pancreatectomy with splenectomy is the standard procedure for cancers of the body and tail of the pancreas. However, this procedure has limitations in terms of the posterior extent of resection and the ability to achieve a complete N1 node resection. A new antegrade procedure has been developed that provides improved visibility, removes N1 nodes, and permits adjustment of the depth of the posterior extent of resection coupled with early rather than late control of the vasculature. Ten patients, 6 with adenocarcinomas of the body of the pancreas, have undergone the procedure since 1999. Nine of 10 patients had negative resection margins, and the median node count in patients who did not receive neoadjuvant radiation was 9 nodes. Three patients had complications develop; no postoperative deaths occurred. Early results with the procedure are encouraging.